echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > GUT: Regular use of proton pump inhibitors is related to an increased risk of type 2 diabetes.

    GUT: Regular use of proton pump inhibitors is related to an increased risk of type 2 diabetes.

    • Last Update: 2020-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Proton pump inhibitors (PPI) are one of the top ten most commonly used drugs in the world.
    PPI is commonly used for acid-related diseases such as gastroesophedic reflow disease, peptic ulcer disease and non-ulcerative indigestion.
    generally believe that short-term use of PPI is safe.
    , long-term use of PPI has been associated with adverse reactions such as fractures, chronic kidney disease, bowel infections and stomach cancer.
    addition, type 2 diabetes has become a global epidemic, with a global prevalence rate of 8.5 per cent in 2014, and the causes of type 2 diabetes are complex and involve a variety of genetic, behavioural and environmental factors.
    recent years, researchers have turned their attention to the role of human gut bacteria, which is critical to expanding the role of host metabolism in the development of diabetes.
    the significant effects of PPI on the gut microbiome, its use may be associated with an increased risk of type 2 diabetes.
    study aims to assess the regular use of PPI and the risk of type 2 diabetes.
    researchers conducted a retrospective study of 204,689 non-diabetic participants.
    confirmed the onset of type 2 diabetes using the American Diabetes Association's (ADA) diagnostic criteria.
    then assessed the effects of demographic factors, lifestyle habits, complications, and other drug use on the risk of developing type 2 diabetes.
    study recorded 10,105 cases of diabetes, and after follow-up of 2127,471 people, the risk of diabetes was 24% higher for the average PPI user than for non-users (HR 1.24, 95% CI 1.17 to 1.31).
    duration of taking PPI increases the risk of diabetes.
    1.05 (95% CI 0.93 to 1.19) for participants who used PPI greater than 2 years compared to non-users.
    , the researchers confirmed that regular use of PPI was associated with a higher risk of type 2 diabetes and increased risk over time.
    , physicians should take extra care when prescribing PPI, especially when using it for long periods of time.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.